The business may not be as strong as its performance this year suggests.

For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of ...

The "Protein Engineering for Pharmaceutical Biotechnology Training Course (Jan 21st - Jan 22nd, 2026)" training has been added to ResearchAndMarkets.com's offering. Enhance your knowledge in protein ...

DOVER, DE, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- The safety of parenteral medicines and medical devices ...

Vertex Pharmaceuticals' late-stage pipeline. Vertex Pharmaceuticals' strategy is to develop medicines in areas with high ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Jan 30 () - CSPC Pharmaceutical Group ​said on ‌Friday it had ‌entered an agreement with UK drugmaker AstraZeneca for ⁠the ...

The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.

During the first six months of this year, the pharmaceutical-biotech industry completed construction on a total of 31 new plants and research centers across North America During the first six months ...

In our final batch of Changing Faces columns for 2025, we’re detailing a flurry of senior leadership appointments in recent months, with companies across the spectrum in experienced executives to ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Ultragenyx Pharmaceutical, Inc. (NASDAQ:RARE) stands ...

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...